A detailed history of Coppell Advisory Solutions LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Coppell Advisory Solutions LLC holds 126 shares of TMDX stock, worth $8,051. This represents 0.0% of its overall portfolio holdings.

Number of Shares
126
Previous 153 17.65%
Holding current value
$8,051
Previous $23 Million 12.99%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$135.68 - $176.11 $3,663 - $4,754
-27 Reduced 17.65%
126 $20.1 Million
Q2 2024

Aug 15, 2024

SELL
$72.62 - $150.62 $6,535 - $13,555
-90 Reduced 37.04%
153 $23 Million
Q4 2023

Feb 14, 2024

BUY
$36.74 - $81.08 $8,927 - $19,702
243 New
243 $19.2 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.03B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Coppell Advisory Solutions LLC Portfolio

Follow Coppell Advisory Solutions LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coppell Advisory Solutions LLC with notifications on news.